Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

Christopher D Verrico, Colin N Haile, Thomas F Newton, Thomas R Kosten, Richard De La Garza
  • Expert Opinion on Investigational Drugs, September 2013, Informa Healthcare
  • DOI: 10.1517/13543784.2013.836488
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Christopher D Verrico